The latest announcement is out from Hims & Hers Health (HIMS).
Hims & Hers Health, Inc. has expanded its board of directors from nine to ten members and welcomed Christopher Payne as the new director, effective immediately. Payne, who is deemed independent according to New York Stock Exchange and Securities Exchange Act standards, will serve until the next annual meeting. He will receive compensation in line with the company’s director compensation program, including an initial award of restricted stock units valued at $400,000. With no familial ties to current executives or undisclosed arrangements influencing his appointment, Payne’s addition is a straightforward enhancement to the Company’s governance.
See more data about HIMS stock on TipRanks’ Stock Analysis page.
